United Therapeutics Corporation
UTHR · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $3.18B | $2.88B | +10.6% |
| Operating income | $1.49B | $1.38B | +8.4% |
| Net income | $1.33B | $1.20B | +11.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $832M | $800M | +4.1% |
| Operating income | $308M | $388M | −20.8% |
| Net income | $259M | $339M | −23.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was United Therapeutics's revenue in FY2025?
- $3.18B in FY2025 (Fiscal year ended Dec 31, 2025), +10.6% vs $2.88B a year earlier, per its 10-K filed Feb 2026.
- Was United Therapeutics profitable in FY2025?
- Yes: net income was $1.33B and operating income $1.49B in FY2025.
- What was United Therapeutics's revenue in Q3 2026?
- $832M (+4.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.